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Lactate Trends in Veno-Arterial Extracorporeal Membrane Oxygenation 
Patients Presenting with Sepsis
Kennedy Gallagher, Niharika Boinpally, Allison Eisenhauer, PA-C, Michael Healy, Kristina Postko, PA-C, James K. Wu, MD
Division of Cardiothoracic Surgery, Lehigh Valley Health Network, Allentown, Pa.
RESULTS
•  Of the 20 sepsis patients who underwent ECMO treatment, 
30% of the patients survived.
n  The average lactate level of patients who survived was  
4.18 mmol/L.
n  The average lactate level of patients who did not survive 
was 8.94 mmol/L.
•  In patients who survived, lactate levels trended down and 
stabilized within the first four days of ECMO treatment while 
lactate levels of the patients who did not survive did not 
return to within the normal range [0.5-2.1].
CONCLUSION
•  Recorded lactate levels before and within the first 4 days of 
ECMO treatment help to determine trends in patient survival.
•  On average, lactate levels well above the normal range 
resulted in a higher mortality rate.
•  Future studies should look to determine if there is a  lactate 
level threshold over which survival is rare. 
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OUTCOMESBACKGROUND
•  Sepsis is a potentially life-threatening medical condition that 
results from the complication of an inflammatory response 
due to infection.1
•  Lactate levels in sepsis patients are elevated as a result of 
organ failure and anaerobic metabolism.2
•  Veno-Arterial Extracorporeal Membrane Oxygenation  
(VA-ECMO) is a specialized form of heart-lung bypass that 
can be used to treat septic patients with myocardial injury.3
OBJECTIVE
•  This study aims to analyze the relationship between  
lactate levels of VA-ECMO-treated sepsis patients and 
survival at discharge.
METHODS
Data collection of patient demographic information, 
related variables, and outcomes
Retrospective chart review of all VA-ECMO  
patients with Sepsis from 2013-2018 at the  
Lehigh Valley Health Network
Analysis and correlational studies between  
lactate levels and patient survival
Figure 1: Demographic information of VA-ECMO 
treated sepsis patients, including subdivisions 


















Average Initial Lactate Level 
of Septic Patients
Figure 2: Difference in average lactate levels upon 
hospital admission between the sepsis patients that 
lived and the sepsis patients that died after ECMO 
treatment
Figure 3: Display of the lactate levels of the seven patients that lived returning to normal physiological levels 
during the first four days of ECMO treatment
Demographic Characteristics of  
VA-ECMO-Treated MI Patients
Characteristic No. (% of n or mean ± SD)
Men 90%
Women 10%
Age 56.0 + 15.1
Survival 30%
Characteristics of Living Patients
Men 100%
Women 0%
Age 58.5 + 13.6
Characteristics of Deceased Patients
Men 86%
Women 14%
Age 54.9 + 16.1
















Day of ECMO (from Cannulation)
La
ct
at
e 
(m
m
ol
/L
)
